about
IOEASMA: an integrated clinical and educational pathway for managing asthma in children and adolescents.Antidepressant and antipsychotic use in an Italian pediatric population.Methods in pharmacoepidemiology: a review of statistical analyses and data reporting in pediatric drug utilization studies.Tuberculosis care for pregnant women: a systematic review.Childhood asthma management pre- and post-incident asthma hospitalization.A scoping review of interventions to supplement spoken communication for children with limited speech or language skills.Impact of the systematic introduction of low-cost bubble nasal CPAP in a NICU of a developing country: a prospective pre- and post-intervention studyOral Ondansetron versus Domperidone for Acute Gastroenteritis in Pediatric Emergency Departments: Multicenter Double Blind Randomized Controlled TrialPostnatal depression screening in a paediatric primary care setting in Italy.Drug versus placebo randomized controlled trials in neonates: A review of ClinicalTrials.gov registry.Geographical epidemiology of antibacterials in the preschool age.Adverse drug reactions in childhood: a review of prospective studies and safety alerts.Child health in Colombia.Children's presence in research. A review of online registers.Psychotropic drug use during breastfeeding: a review of the evidence.Ureaplasma, bronchopulmonary dysplasia, and azithromycin in European neonatal intensive care units: a survey.Pain management in the paediatric population: the regulatory situation in Europe.Safety of medicines used for ADHD in children: a review of published prospective clinical trials.Review of Italian primary care paediatricians identifies 38 commonly prescribed drugs for children.The evolution in registration of clinical trials: a chronicle of the historical calls and current initiatives promoting transparency.Mental disorders and transition to adult mental health services: A scoping review.Fast and reliable artemisinin determination from different Artemisia annua leaves based alimentary products by high performance liquid chromatography-tandem mass spectrometry.Antiepileptic drug use in Italian children over a decade.The impact of a model-based clinical regional registry for attention-deficit hyperactivity disorder.Screening, diagnosis and management of human cysticercosis and Taenia solium taeniasis: technical recommendations by the COHEMI project study group.A Regional ADHD Center-Based Network Project for the Diagnosis and Treatment of Children and Adolescents With ADHD.Psychotropic medicine prescriptions in Italian youths: a multiregional study.Serological screening for celiac disease in a northern Italian child and adolescent population after the onset of type 1 diabetes: a retrospective longitudinal study of a 7-year period.Transition to Adult Mental Health Services for Young People With ADHD.Clinical trial registries: more international, converging efforts are needed.Burden of psychiatric disorders in the pediatric population.Comparing recurrent antibiotic prescriptions in children treated with a brand name or a generic formulation.More and better should be done to guarantee evidence-based management of ADHD in children across Europe.Antibiotic and anti-asthmatic drug prescriptions in Italy: geographic patterns and socio-economic determinants at the district level.Off-label drug use in children should be rational.Spirometry testing in a population of Italian children: age and gender differences.Pediatric pharmacoepidemiology - safety and effectiveness of medicines for ADHD.Licensed medicines, off-label use or evidence-based. Which is most important?Transition to adult mental health services for young people with attention deficit hyperactivity disorder in Italy: Parents' and clinicians' experiences.Neonatal drug trials: impact of EU and US paediatric regulations
P50
Q33831133-31F01EBA-1FAF-4AA4-8348-1B869DF1C370Q33909185-A8908AB5-7AE2-483D-8A01-AA7134A506FCQ34351816-D9497F89-DBE0-4A46-B69F-F6DD0EE60686Q34560317-3FF44628-FEDA-4AAC-9BCA-E12AEF3BBC11Q35034685-79F67265-BA15-4299-B1EC-4E22DBA151E8Q35119737-EF956428-8E1F-4F7D-AA8E-B1DAEB3344DFQ35222972-E6148FD2-7164-46A0-ABB1-A7A96CDAD359Q36202546-3B0085B1-B291-4717-B78B-BDABC1FE0B92Q36260159-11F8E25C-DF39-4158-BD66-B4D2297D9BA5Q36278708-5A2D54D2-3C43-40EA-9305-B3B563AD63A2Q36517570-02C9A25F-CCB0-459A-84CD-EC1283AD2FC1Q37521364-B0FAD1EB-CE11-4CC5-AA6B-C05F6C75F693Q37545062-19B0A859-13CA-4926-AD27-67585CD474A9Q37546946-1F0F3A37-206B-4534-864F-AD2040863028Q37593393-7EBFC893-813E-4011-A705-FAE74C147587Q37736570-F2C05BFC-9FD6-47FE-98B8-08881E166E24Q37768286-35973597-3A84-4970-8E50-4C93A688F91BQ38205749-5DA4012C-8383-4079-A04A-8FDA6FDE1627Q38244068-03BA3F9A-2AB4-4E6B-B913-448C5F92A7E1Q38560675-993D059C-D68F-480F-91CE-E91C5E011EBEQ38662998-20CF214A-B7B1-4E75-A22D-D8F5F89DE02DQ38933115-68CD55B5-24B9-4C91-BBAE-66921E0B650FQ39151495-A95D24E6-53F0-4B46-A81D-F73B9368F221Q39905721-6E0FCAD0-0624-4CDF-9225-B87240352017Q40235042-66D48ADA-4DE8-4BC6-BE0B-FA90E10CA255Q40593673-0208BEF2-86C9-4CBD-AF3E-B493238D9D09Q40897841-277BF2F2-23B2-4DF6-A5F3-3537902F0ABBQ40923558-5C3F7382-3706-4D6B-AD34-5288D6F535FDQ41668542-BC02DAF0-FCDD-464C-B0B2-6B77A373C407Q42319396-42CFB253-4A7B-43DB-AD96-6C136A05967BQ43561162-18932A0C-42C7-4F01-B614-5BF46ADE54EEQ44611803-15A30045-39F3-4E7F-BBDE-5F437264CFD8Q45422010-6679F32A-8EF5-48D8-8312-49F4E9767C3BQ45760178-5F029A2C-7A93-429E-AE53-1B9AED541562Q45847915-49210632-E930-446B-BB80-21C6134A9253Q46634348-3F2FAC76-E30F-4D16-93F2-D5C720242B4BQ47677209-BBDB4558-93C9-46BB-AE03-988299DFD1E2Q48107012-2A8F1AC4-E4E5-4DBE-BB65-5FA46D5A40F5Q50577639-ACFC7A84-C331-4145-AA53-CF905E0C9D57Q57413139-80A06272-67FF-4A7A-BBA3-FA6254B26E17
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Maurizio Bonati
@en
Maurizio Bonati
@nl
type
label
Maurizio Bonati
@en
Maurizio Bonati
@nl
prefLabel
Maurizio Bonati
@en
Maurizio Bonati
@nl
P31
P496
0000-0003-3997-3726